On August 3, 2026, ABVC BioPharma, Inc. (the "Company") determined to postpone the previously announced distribution of ordinary shares of BioKey (Cayman), Inc. (the "Distribution"), which had been scheduled to occur on August 3, 2026. The Company has now determined that the Distribution will now occur on August 21, 2026. The postponement provided the Company with additional time to complete certain administrative, regulatory and tax-related matters necessary to effect the Distribution.

 

The Company coordinated with The Nasdaq Stock Market LLC, The Depository Trust Company and the Company’s transfer agent regarding the revised distribution mechanics and the establishment of the new distribution date of August 21, 2026.

 

The previously announced record date of July 24, 2026 remains unchanged, and the distribution ratio will remain 0.169464 ordinary shares of BioKey (Cayman), Inc. for each share of the Company’s common stock held as of the record date. The previously announced ex-dividend date will no longer apply and will be revised in connection with the new distribution date of August 21, 2026.

 

The Company intends to announce the corresponding ex-dividend date after such date has been finalized and the remaining administrative, regulatory, and tax-related matters have been completed.